Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – What’s Next?

Elekta AB (OTCMKTS:EKTAY) saw unusually-strong trading volume on Monday . Approximately 4,966 shares traded hands during trading, an increase of 107% from the previous session’s volume of 2,403 shares.The stock last traded at $4.9550 and had previously closed at $5.0250.

Wall Street Analysts Forecast Growth

Separately, Zacks Research lowered Elekta from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Sell rating, Based on data from MarketBeat.com, Elekta currently has a consensus rating of “Sell”.

Elekta Stock Down 1.7%

The firm has a 50-day moving average price of $5.89 and a two-hundred day moving average price of $6.06. The firm has a market cap of $1.82 billion, a price-to-earnings ratio of -30.88 and a beta of 1.00. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. The firm had revenue of $521.00 million during the quarter. Elekta had a positive return on equity of 10.67% and a negative net margin of 3.32%. On average, sell-side analysts forecast that Elekta AB will post 0.43 earnings per share for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.